Medico Remedies Ltd

Clarification on price movement

• No pending information to disclose under SEBI LODR Regulations, 2015.
• Price/volume movement is market-driven and not due to undisclosed information.
• Company regularly shares all material information with the stock exchange as events occur.

Financial results (Standalone, Q1 FY27)

• Revenue from operations for quarter ended 30-Jun-2026: Rs 6,903.36 lakh.
• Total income for quarter ended 30-Jun-2026: Rs 7,056.92 lakh.
• Total comprehensive income for the period: Rs 209.03 lakh.
• Domestic sales India: Rs 2,633.62 lakh; exports Rs 4,269.74 lakh.
• Basic EPS Rs 5.30; diluted EPS Rs 0.71.
• Board approved Q1 standalone results with Limited Review Report.
• Rishit Mehta re-appointed as Whole-Time Director from 18 Sep 2026 for three years.
• Haresh Mehta re-appointed as Chairman & Whole-Time Director from 18 Sep 2026 for three years.
• MD Harshit Mehta remuneration increased.

Meeting Details

• Board meeting scheduled for 13 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited quarterly results for the quarter ended 30 June 2026 with Limited Review Report.
• Any other business with the permission of the Chair.

Other Notes

Medico Remedies Limited: Trading Window closed from 1 July 2026 up to 48 hours post the declaration of Unaudited Financial Results for the quarter ended 30 June 2026

🗓️ Meeting Details

• Board meeting scheduled for 12 February 2026.

📊 Key Agenda Items

• Approval of unaudited financial results for quarter ended 31 December 2025.
• Consideration of limited review report on the financial results.

Order Award Details

• Uttar Pradesh Medical Supplies Corporation Limited, a Government of Uttar Pradesh entity, awarded the order.
• The order involves supply of multiple drugs to Uttar Pradesh Medical Supplies Corporation Limited.
• Total order value is approximately INR 37.18 crore (tax inclusion not specified).
• The awarding entity is domestic (Government of Uttar Pradesh).
• Supply completion deadline is 31st October 2026.
• The order is not a related party transaction and involves no promoter group interest.

Order Award Details

• Order awarded by Uttar Pradesh Medical Supplies Corporation Limited, a government entity of Uttar Pradesh.
• Contract involves supply of Azithromycin 500mg tablets.
• Total order value is approximately INR 73.23 crore.
• The awarding entity is domestic.
• Supply completion deadline is 31st October 2026.
• No promoter or promoter group interest; not a related party transaction.